Technology
Health
Biotechnology

Strongbridge Biopharma

$4.79
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.36 (-6.99%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell SBBP and other stocks, options, ETFs, and crypto commission-free!

About

Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. Read More The company was founded on May 26, 2015 and is headquartered in Lower Southampton, PA.

Employees
66
Headquarters
Lower Southampton, Pennsylvania
Founded
2015
Market Cap
243.00M
Price-Earnings Ratio
8.43
Dividend Yield
0.00
Average Volume
397.22K
High Today
$5.26
Low Today
$4.43
Open Price
$5.25
Volume
251.29K
52 Week High
$9.25
52 Week Low
$3.82

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
2015 IPO
US
North America

News

The Motley FoolFeb 26

Strongbridge Biopharma plc (SBBP) Q4 2018 Earnings Conference Call Transcript

Strongbridge Biopharma plc (NASDAQ:SBBP) Q4 2018 Earnings Conference Call , 8:30 a.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good morning, ladies and gentlemen, and welcome to the Strongbridge Biopharma Corporate Update and Fourth Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. (Operator Instructions...

90
Seeking AlphaFeb 26

Strongbridge Biopharma beats by $0.03, misses on revenue

Strongbridge Biopharma (NASDAQ:SBBP): Q4 Non-GAAP EPS of -$0.46 beats by $0.03; GAAP EPS of $1.64 beats by $2.13. Revenue of $4.51M (+51.3% Y/Y) misses by $0.9M . Press Release...

84

Earnings

-$0.49
-$0.43
-$0.37
-$0.31
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 9, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.